Slides presented at the July 13, 2010 press conference announcing the final rules for Meaningful Use. These rules define what qualifies for stimulus incentive payments under the ARRA/HITECH legislation.
Slides presented at the July 13, 2010 press conference announcing the final rules for Meaningful Use. These rules define what qualifies for stimulus incentive payments under the ARRA/HITECH legislation.
Meaningful Use encompasses multiple stages, each with specific timeline and measure requirements that continue to be a moving target. This can be a confusing process, sending providers in a tailspin in their attempts to stay current. This webinar focuses on the overall details of Meaningful Use and provides a nice outline of all of its details.
www.interlinkconsultancy.com
Healthcare industry challenges and pharmacoeconomic solutions.The pharma industry product pipelines are drying up, leading to a high dependence on existing products for survival. The branded generic drugs segment has become commoditized due to ever increasing and fierce
competition.Price plays a major role in drug prescription and buying decisions. High price may not always assure high quality or more benefits and companies are finding it difficult to substantiate higher prices..
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
Meaningful Use encompasses multiple stages, each with specific timeline and measure requirements that continue to be a moving target. This can be a confusing process, sending providers in a tailspin in their attempts to stay current. This webinar focuses on the overall details of Meaningful Use and provides a nice outline of all of its details.
www.interlinkconsultancy.com
Healthcare industry challenges and pharmacoeconomic solutions.The pharma industry product pipelines are drying up, leading to a high dependence on existing products for survival. The branded generic drugs segment has become commoditized due to ever increasing and fierce
competition.Price plays a major role in drug prescription and buying decisions. High price may not always assure high quality or more benefits and companies are finding it difficult to substantiate higher prices..
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
Keynote Presentation "Meaningful Use Stage 2 and Meaningful Use Audit Insight"
Think far beyond just threshold increases. The differences between Meaningful Use (MU) Stage 1 and Stage 2, including the 2014 Clinical Quality Measures, are technically and clinically challenging. And just when you thought you could safely look at Stage 1 in the rearview mirror, here come the audits! I will highlight the Stage 1 and Stage 2 differences and talk about the challenges they have initiated at Tenet. I will touch on the impact of Quality measures and will also provide you with insight into the basics of MU Audits and will take you through the actual audit experience at Tenet.
Learning Objectives:
∙ Review the program and measure changes from Stage 1 to Stage 2 and how the changes are being managed at Tenet
∙ Provide insight into the 2014 Clinical Quality Measures chosen by Tenet, the challenges posed, solutions that work and a little about the overall
impact of Quality measures
∙ Discuss Meaningful Use Audits, covering the basics as well as providing the benefit of the Tenet experience
The proposed Trusted Exchange Framework supports ONC’s goals of achieving nationwide interoperability:
Patient Access - Patients must be able to access their health information electronically without any special effort;
Population-level Data Exchange - Providers and payer organizations accountable for managing benefits can receive population level health information allowing them to analyze population health trends, outcomes, and costs; identify at-risk populations; and track progress on quality improvement initiatives; and
Open and Accessible APIs – The health information technology (health IT) community should have open and accessible application programming interfaces (APIs) to encourage entrepreneurial, user-focused innovation to make health information more accessible and to improve electronic health record (EHR) usability.
2015 Edition Proposed RuleModifications to the ONC Health IT Certification ...Brian Ahier
Presentation to April 7, 2015 Health IT Policy Committee:
2015 Edition Proposed RuleModifications to the ONC Health IT Certification Program and 2015 Edition Health IT Certification Criteria
Remarks to Public Forum on National Health IT PolicyBrian Ahier
On February 4, 2010 there was a public forum on the rollout of national HIT policy under HITECH, including "meaningful use," EHR certification, and HIE. Aneesh Chopra, at the time serving as Chief Technology Office (CTO) of the United States made some remarks.
FTC Spring Privacy Series: Consumer Generated and Controlled Health DataBrian Ahier
Increasingly, consumers are taking a more active role in managing and generating their own health data. For example, consumers are researching their health conditions and diagnosing themselves online. Consumers are also uploading their information into personal health records and apps that allow them to manage and analyze their data, and utilizing connected health and fitness devices that regularly collect information about them and transmit this information to other entities.
The movement of health data outside the traditional medical provider context has many potential benefits; however, it also raises potential privacy concerns. The seminar will address questions such as:
What types of websites, products, and services are consumers using to generate and control their health data, and how are consumers using them?
Who are the companies behind these websites, products, and services, what are their business models, and what does the current marketplace look like?
How can consumers benefit from these companies’ websites, products, and services?
What actions are these companies taking to protect consumers’ privacy and security?
What do consumers expect from these companies regarding privacy and security protections?
Do consumers differentiate between these companies and those that offer traditional medical products and services that are covered by HIPAA?
What restrictions, if any, do advertising networks and others impose on tracking of health data?
On February 19, 2014, the Federal Trade Commission staff hosted a seminar on Mobile Device Tracking.
The speakers discussed how retailers and other businesses have been tracking consumers’ movements throughout and around retail stores and other attractions using technologies that identify signals emitted by their mobile devices. While the technologies differ, many work by identifying and collecting the MAC address – which is unique to a particular device – broadcast when a mobile device searches for Wi-Fi networks. Companies can use these technologies to reveal information about consumers including the path taken throughout a location, length of time in one location, whether a visitor is new or returning, and the frequency of visits to a location. According to media reports, major retailers in the United States are using or have tested the technology in their stores in order to gain insights into the behavior of their customers.
In most cases, this tracking is invisible to consumers and occurs with no consumer interaction. As a result, the use of these technologies raises a number of potential privacy concerns and questions.
Big Data and VistA Evolution, Theresa A. Cullen, MD, MSBrian Ahier
Presentation to Open Source Electronic Health Record Alliance (OSEHRA) Architecture Work Group by Theresa A. Cullen, MD, MS
Chief Medical Information Officer
Director, Health Informatics
Office of Informatics and Analytics
Veterans Health Administration
Department of Veterans Affairs
Direct Boot Camp 2 0 IWG Provider Directory Pilots
HIT Standards Committee Trudel CMS Rules
1. Medicare & Medicaid EHR Incentive Program Final Rule Implementing the American Recovery & Reinvestment Act of 2009
2.
3.
4.
5.
6.
7.
8.
9.
10. Meaningful Use: Changes from the NPRM to the Final Rule NPRM Final Rule Meet all MU reporting objectives Must meet “core set”/can defer 5 from optional “menu set” 25 measures for EPs/23 measures for eligible hospitals 25 measures for EPs/24 for eligible hospitals Measure thresholds range from 10% to 80% of patients or orders (most at higher range) Measure thresholds range from 10% to 80% of patients or orders (most at lower to middle range) Denominators – To calculate the threshold, some measures required manual chart review Denominators – No measures require manual chart review to calculate threshold Administrative transactions (claims and eligibility) included Administrative transactions removed Measures for Patient-Specific Education Resources and Advanced Directives discussed but not proposed Measures for Patient-Specific Education Resources and Advanced Directives (for hospitals) included
11. Meaningful Use: Changes from the NPRM to the Final Rule, cont’d NPRM Final Rule States could propose requirements above/beyond MU floor, but not with additional EHR functionality States’ flexibility with Stage 1 MU is limited to seeking CMS approval to require 4 public health-related objectives to be core instead of menu Core clinical quality measures (CQM) and specialty measure groups for EPs Modified Core CQM and removed specialty measure groups for EPs 90 CQM total for EPs 44 CQM total for EPs – must report total of 6 35 CQM total for eligible hospitals and 8 alternate Medicaid CQM 15 CQM total for eligible hospitals 5 CQM overlap with CHIPRA initial core set 4 CQM overlap with CHIPRA initial core set
12.
13.
14.
15.
16. Meaningful Use – Stage 1 Core Set Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Use CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local, and professional guidelines More than 30% of unique patients with at least one medication in their medication list seen by the EP or admitted to the eligible hospital or CAH have at least one medication entered using CPOE Implement drug-drug and drug-allergy interaction checks The EP/eligible hospital/CAH has enabled this functionality for the entire EHR reporting period EP Only: Generate and transmit permissible prescriptions electronically (eRx) More than 40% of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology Record demographics: preferred language, gender, race, ethnicity, date of birth, and date and preliminary cause of death in the event of mortality in the eligible hospital or CAH More than 50% of all unique patients seen by the EP or admitted to the eligible hospital or CAH have demographics as recorded structured data Maintain up-to-date problem list of current and active diagnoses More than 80% of all unique patients seen by the EP or admitted to the eligible hospital or CAH have at least one entry or an indication that no problems are known for the patient recorded as structured data
17. Meaningful Use – Stage 1 Core Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Maintain active medication list More than 80% of all unique patents seen by the EP or admitted to the eligible hospital or CAH have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data Maintain active medication allergy list More than 80% of all unique patents seen by the EP or admitted to the eligible hospital or CAH have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data Record and chart vital signs: height, weight, blood pressure, calculate and display BMI, plot and display growth charts for children 2-20 years, including BMI For more than 50% of all unique patients age 2 and over seen by the EP or admitted to the eligible hospital or CAH, height, weight, and blood pressure are recorded as structured data Record smoking status for patients 13 years old or older More than 50% of all unique patients 13 years or older seen by the EP or admitted to the eligible hospital or CAH have smoking status recorded as structured data Implement one clinical decision support rule and the ability to track compliance with the rule Implement one clinical decision support rule Report clinical quality measures to CMS or the States For 2011, provide aggregate numerator, denominator, and exclusions through attestation; For 2012, electronically submit clinical quality measures
18. Meaningful Use – Stage 1 Core Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Engage patients and families in their healthcare Provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies, discharge summary, procedures), upon request More than 50% of all unique patients of the EP, eligible hospital or CAH who request an electronic copy of their health information are provided it within 3 business days Hospitals Only: Provide patients with an electronic copy of their discharge instructions at time of discharge, upon request More than 50% of all patients who are discharged from an eligible hospital or CAH who request an electronic copy of their discharge instructions are provided it EPs Only: Provide clinical summaries for each office visit Clinical summaries provided to patients for more than 50% of all office visits within 3 business days Improve care coordination Capability to exchange key clinical information (ex: problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically Performed at least one test of the certified EHR technology’s capacity to electronically exchange key clinical information Ensure adequate privacy and security protections for personal health information Protect electronic health information created or maintained by certified EHR technology through the implementation of appropriate technical capabilities Conduct or review a security risk analysis per 45 CFR 164.308(a)(1) and implement updates as necessary and correct identified security deficiencies as part of the EP’s, eligible hospital’s or CAH’s risk management process
19. Meaningful Use – Stage 1 Menu Set Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Implement drug-formulary checks The EP/eligible hospital/CAH has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period Hospitals Only: Record advance directives for patients 65 years old or older More than 50% of all unique patients 65 years old or older admitted to the eligible hospital or CAH have an indication of an advance directive status recorded Incorporate clinical lab-test results into certified EHR technology as structured data More than 40% of all clinical lab test results ordered by the EP, or an authorized provider of the eligible hospital or CAH, for patients admitted during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach Generate at least one report listing patients of the EP, eligible hospital or CAH with a specific condition EPs Only: Send reminders to patients per patient preference for preventive/follow-up care More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period
20. Meaningful Use – Stage 1 Menu Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Engage patients and families in their health care EPs Only: Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, medication allergies) within 4 business days of the information being available to the EP More than 10% of all unique patients seen by the EP are provided timely (available to the patient within 4 business days of being updated in the certified EHR technology) electronic access to their health information subject to the EP’s discretion to withhold certain information Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient, if appropriate More than 10% of all unique patients seen by the EP or admitted to the eligible hospital or CAH are provided patient-specific education resources Improve care coordination The EP, eligible hospital or CAH who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation The EP, eligible hospital or CAH performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP or admitted to the eligible hospital or CAH The EP, eligible hospital or CAH who receives a patient from another setting of care or provider of care or refers their patient to another provider of care should provide a summary of care record for each transition of care or referral The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals
21. Meaningful Use – Stage 1 Menu Set, cont’d 1 Unless an EP, eligible hospital or CAH has an exception for all of these objectives and measures they must complete at least one as part of their demonstration of the menu set in order to be a meaningful EHR user. Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improve population and public health 1 Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission in accordance with applicable law and practice Performed at least one test of the certified EHR technology’s capacity to submit electronic data to immunization registries and follow-up submission if the test is successful (unless none of the immunization registries to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically) Hospitals Only: Capability to submit electronic data on reportable (as required by state or local law) lab results to public health agencies and actual submission in accordance with applicable law and practice Performed at least one test of certified EHR technology’s capacity to provide submission of reportable lab results to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically) Capability to submit electronic syndromic surveillance data to public health agencies and actual submission in accordance with applicable law and practice Performed at least one test of certified EHR technology’s capacity to provide electronic syndromic surveillance data to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically)
22.
23.
24.
25.
26.
27.
28. CQM: Core Set for EPs NQF Measure Number & PQRI Implementation Number Clinical Quality Measure Title NQF 0013 Hypertension: Blood Pressure Measurement NQF 0028 Preventive Care and Screening Measure Pair: a) Tobacco Use Assessment b) Tobacco Cessation Intervention NQF 0421 PQRI 128 Adult Weight Screening and Follow-up
29. CQM: Alternate Core Set for EPs NQF Measure Number & PQRI Implementation Number Clinical Quality Measure Title NQF 0024 Weight Assessment and Counseling for Children and Adolescents NQF 0041 PQRI 110 Preventive Care and Screening: Influenza Immunization for Patients 50 Years Old or Older NQF 0038 Childhood Immunization Status
30.
31.
32.
33. Participation in HITECH and other Medicare Incentive Programs for EPs Other Medicare Incentive Program Eligible for HITECH EHR Incentive Program? Medicare Physician Quality Reporting Initiative (PQRI) Yes, if the EP is eligible. Medicare Electronic Health Record Demonstration (EHR Demo) Yes, if the EP is eligible. Medicare Care Management Performance Demonstration (MCMP) Yes, if the practice is eligible. The MCMP demo will end before EHR incentive payments are available. Electronic Prescribing (eRx) Incentive Program If the EP chooses to practice in the Medicare EHR Incentive Program, they cannot participate in the Medicare eRx Incentive Program simultaneously in the same program year. If the EP chooses to participate in the Medicaid EHR Incentive Program, they can participate in the Medicare eRx Incentive Program simultaneously.
34.
35.
Editor's Notes
Logo: EHR Incentive Programs (Tagline: Connecting America for Better Health) Logo: CMS – Centers for Medicare and Medicaid Services
NPRM vs. Final Rule Meet all MU reporting objectives vs. Must meet “core set”/can defer 5 from optional “menu set” 25 measures for EPs/23 for eligible hospitals vs. 25 measures for EPs/24 for eligible hospitals Measure thresholds range from 10% to 80% of patients or orders (most at higher range) vs. Measure thresholds range from 10% to 80% of patients or orders (most at lower to middle range) Denominators – To calculate the threshold, some measures required manual chart review vs. Denominators – No measures require manual chart review to calculate threshold (Speaker Note: Manual chart review including the counting of orders. For the final rule, the only counting that would be required would be to know the number of patients seen or admitted during the EHR reporting period. All other denominators can be obtained automatically using certified EHR technology. ) Administrative transactions (claims and eligibility) included vs. Administrative transactions removed Measures for Patient-Specific Education Resources and Advanced Directives discussed but not proposed vs. Measures for Patient-Specific Education Resources and Advanced Directives (for hospitals) included
NPRM vs. Final Rule, continued States could propose above/beyond MU floor, but not with additional EHR functionality vs. States’ flexibility with Stage 1 MU is limited to seeking CMS approval to require 4 public health-related objectives to be core instead of menu Core CQM and specialty measure groups for EPs vs. Modified Core CQM and removed specialty measure groups for EPs 90 CQM total for EPs vs. 44 CQM total for EPs – must report total of 6 35 CQM total for eligible hospitals and 8 alternate Medicaid CQM vs. 15 CQM total for eligible hospitals 5 CQM overlap with CHIPRA initial core set vs. 4 CQM overlap with CHIPRA initial core set
Core Set CQM for EPs Hypertension: Blood Pressure Measurement (NQF 0013) Preventive Care and Screening Measure Pair: a) Tobacco Use Assessment b) Tobacco Cessation Intervention (NQF 0028) Adult Weight Screening and Follow-up (NQF 0421, PQRI 128)
Alternate Core CQM Set for EPs Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Preventive Care and Screening: Influenza Immunization for Patients > 50 Years old (NQF 0041, PQRI 110) Childhood Immunization Status (NQF 0038)
Other Medicare Incentive Program -- Eligible for HITECH? Medicare Physician Quality Reporting Initiative (PQRI) -- Yes, if the EP is eligible. Medicare Electronic Health Records Demonstration (EHR Demo) -- Yes, if the EP is eligible. Medicare Care Management Performance Demonstration (MCMP) -- Yes, if the practice is eligible. The MCMP demo will end before EHR incentive payments are available. Electronic Prescribing (eRx) Incentive Program -- If the EP chooses to practice in the Medicare EHR Incentive Program, they cannot participate in the Medicare eRx Incentive Program simultaneously in the same program year. If the EP chooses to participate in the Medicaid EHR Incentive Program, they can participate in the Medicare eRx Incentive Program simultaneously.